Concepedia

Zhengkui Sun

ZS

Statistics

Publications

4

Citations

162

H-Index

4

Active since

2006

Affiliations

Jiangxi Provincial Cancer Hospital(Current)

Chongqing University

Liaoning Cancer Hospital & Institute

Kelun Group (China)

Dalian Medical University

Zhengkui Sun is an author at Jiangxi Provincial Cancer Hospital specializing in immunotherapy, chemotherapy, and targeted therapy.

Publications per year

2006–2025

4

Publications

4

An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer

Zhengkui Sun, Shengchun Liu, Hua Tang et al. · Immunobiology · 2006 · 55 citations

Life Sciences, Immunology, Molecular Biology +14

Sacituzumab tirumotecan (SKB264/MK-2870) in patients (pts) with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the phase III OptiTROP-Breast01 study.

Binghe Xu, Yongmei Yin, Ying Fan et al. · Journal of Clinical Oncology · 2024 · 45 citations

Medicine, Oncology, Pharmacology +17

Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial

Yongmei Yin, Ying Fan, Quchang Ouyang et al. · Nature Medicine · 2025 · 45 citations

Medicine, Oncology, Pharmacology +14

Microenvironmental G protein‐coupled estrogen receptor‐mediated glutamine metabolic coupling between cancer‐associated fibroblasts and triple‐negative breast cancer cells governs tumour progression

Chongwu He, Meixi Peng, Xiaoqiang Zeng et al. · Clinical and Translational Medicine · 2024 · 17 citations · Full text

Medicine, Cell Biology, Oncology +17

1–4 of 4